Journey Medical Corp (DERM)
3.45
-0.17
(-4.70%)
USD |
NASDAQ |
May 17, 16:00
3.45
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Net Income (Quarterly): -10.44M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.44M |
| December 31, 2023 | -2.143M |
| September 30, 2023 | 16.79M |
| June 30, 2023 | -8.363M |
| March 31, 2023 | -10.14M |
| December 31, 2022 | -10.64M |
| September 30, 2022 | -10.08M |
| June 30, 2022 | -7.528M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.378M |
| December 31, 2021 | -21.75M |
| September 30, 2021 | -10.65M |
| June 30, 2021 | -11.86M |
| March 31, 2021 | 0.268M |
| December 31, 2020 | 2.502M |
| September 30, 2020 | 0.029M |
| June 30, 2020 | 0.455M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-21.75M
Minimum
Dec 2021
16.79M
Maximum
Sep 2023
-5.308M
Average
-7.946M
Median
Net Income (Quarterly) Benchmarks
| Fortress Biotech Inc | -9.279M |
| Stereotaxis Inc | -4.507M |
| GT Biopharma Inc | -2.962M |
| Cara Therapeutics Inc | -30.70M |
| FibroGen Inc | -32.93M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 13.03M |
| Total Expenses (Quarterly) | 23.12M |
| EPS Diluted (Quarterly) | -0.53 |
| Enterprise Value | 62.93M |
| Gross Profit Margin (Quarterly) | 47.69% |
| Profit Margin (Quarterly) | -80.14% |
| Earnings Yield | -8.99% |
| Operating Earnings Yield | 0.80% |
| Normalized Earnings Yield | -3.701 |